'Influenza vaccination of healthy working adults younger than 65 years can reduce the rates of ILI (illness), lost workdays, and physician visits during years when the vaccine and circulating viruses are similar, but vaccination may not provide overall economic benefits in most years'. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K. JAMA. 2000;284:1655-1663.
'The analysis suggests that providing an influenza vaccination programme can incur a substantial net benefit for an employer, although the size of the benefit will depend upon who normally absorbs the costs of treating influenza and compensating workers for lost work time due to illness, as well as the type of company in which the immunisation programme is applied.' Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company. Burckel E, Ashraf T, de Sousa Filho JP, Forleo Neto E, Guarino H, Yauti C, Barreto F de B, Champion L. Pharmacoeconomics. 1999 Nov;16(5 Pt 2):563-76.
more >>
'Influenza vaccination of healthy working adults on average is cost saving. These findings support a strategy of routine, annual vaccination for this group, especially when vaccination occurs in efficient and low-cost sites.' Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Nichol KL. Arch Intern Med. 2001 Mar 12;161(5):749-59.
' The "cost per saved lost workday" was $22.36, for a company savings of $2.58 per dollar invested in the vaccination program. We concluded that the influenza vaccine can give significant reductions in incidence, absenteeism, and cost associated with ILJ in the workplace.' Cost-effectiveness of the influenza vaccine in a healthy, working-age population. Campbell DS, Rumley MH. J Occup Environ Med. 1997 May;39(5):408-14.
' Implementation of an occupational vaccination programme with Influvac would be expected to reduce the incidence of influenza among a workforce leading to less absenteeism from work and averted lost productivity. Even if the incidence of influenza was as low as 2% it may be a worthwhile investment for UK employers to vaccinate their employees with Influvac.' A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac in the UK. Das Gupta R, Guest JF.
Pharmacoeconomics. 2002;20(7):475-84.
' Approximately 10% of the general population worldwide acquires influenza infection every year.' 'The data indicates that influenza vaccination is safe in airline flight crews and may produce health-related benefits including reduced absenteeism.' Impact of influenza vaccination on civilian aircrew illness and absenteeism. Mixeu MA, Vespa GN, Forleo-Neto E, Toniolo-Neto J, Alves PM. Aviat Space Environ Med. 2002 Sep;73(9):876-80.
Certification Number EO10000521
